A report highlights that major pharmaceutical companies are prioritizing AI integration, planning increased investments. Technologies such as machine learning and predictive analytics are being explored to enhance drug discovery and patient outcomes, reflecting shifts in the landscape of drug development across the U.S. and Europe.
💊 AI Adoption Accelerates in Big Pharma Sector
